Delivery Order SPE2DX22D0010-SPE2D826FAY27
- Not listed
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on November 2, 2025, for the supply of OxyContin 20mg tablets under a firm fixed-price contract valued at $5,072.23. This non-set-aside award is scheduled for completion by November 3, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with the Defense Logistics Agency. AmerisourceBergen, a major pharmaceutical distributor...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $5,702.74 for OxyContin tablets (20mg) on August 24, 2025, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The work will be...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 10, 2025, for the supply of OxyContin tablets (20mg) with a ceiling value of $3,304.45. This firm fixed-price delivery order is scheduled for completion by August 11, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 20, 2025, for OxyContin tablets (20mg) with a ceiling value of $3,304.45. This is a firm fixed-price delivery order, classified as a child contract with no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. The contract has an ultimate completion...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $5,072.23 for OxyContin tablets (20mg) by the Department of Defense Medical Supply Chain, with an award date of October 5, 2025, and ultimate completion by October 6, 2025. The contract is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 8, 2025, for the supply of OxyContin tablets (20 mg) with a ceiling value of $3,184.28. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is set to conclude on June 9, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- On September 12, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $6,544.19 to AmerisourceBergen Drug Corp for the supply of OxyContin ER 20 mg tablets (100-count units). The contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. Performance will be completed by September 15, 2025, at the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- AmerisourceBergen Drug Corp received a competitively awarded delivery order from the Defense Logistics Agency's Medical Supply Chain for OxyContin 20mg tablets with a ceiling value of $5,702.74. The contract, awarded on September 28, 2025, with an ultimate completion date of September 29, 2025, represents a firm fixed-price transaction with no set-aside designation. Performance will be executed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $6,007.92 on September 12, 2025, for the supply of OxyContin ER 20 mg tablets (100-count units). The contract is competitively awarded with no set-aside designation and features firm fixed pricing, with an ultimate completion date of September 15, 2025. The award is funded by the Defense Logistics Agency's Medical Supply Chain, a division of the...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of OxyContin ER 20 mg tablets in quantities of 100 units. This firm fixed-price delivery order has a ceiling value of $4,833.03 and is scheduled for completion by September 12, 2025. The contract was competitively awarded without set-aside provisions, leveraging AmerisourceBergen's established capabilities as a critical pharmaceutical distributor...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FAY27Delivery Order
The Defense Department's Medical Supply Chain awarded a delivery order valued at $5,072.23 to AmerisourceBergen Drug Corp on November 9, 2025, for the supply of OxyContin tablets (20mg). This is a firm fixed-price delivery order with an ultimate completion date of November 10, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs and holds a significant Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical valued at $999,999,999.00 through December 2026. This delivery order is issued under AmerisourceBergen's comprehensive prime IDC vehicle, which enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities across multiple therapeutic domains and serves customers including the Defense Health Agency and the U.S. Coast Guard. The delivery order demonstrates the company's ongoing role as a preferred vendor for controlled pharmaceutical substances and other essential medical supplies required by the Department of Defense healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.1k | 11/9/25 |